vs
Astrana Health, Inc.（ASTH）とUbiquiti Inc.（UI）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $814.9M、Ubiquiti Inc.の約1.2倍）。Ubiquiti Inc.の純利益率が高く（28.7% vs 0.7%、差は28.0%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 35.8%）。Ubiquiti Inc.の直近四半期フリーキャッシュフローが多い（$260.3M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 28.6%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
Ubiquiti Inc.は2003年に米国カリフォルニア州サンノゼで設立されたテクノロジー企業で、現在はニューヨークに本社を置いています。複数のブランドを展開し、企業および一般家庭向けの有線・無線データ通信機器の製造・販売を事業の柱としています。
ASTH vs UI — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $814.9M |
| 純利益 | $6.6M | $233.6M |
| 粗利率 | — | 45.9% |
| 営業利益率 | 1.9% | 35.9% |
| 純利益率 | 0.7% | 28.7% |
| 売上前年比 | 42.9% | 35.8% |
| 純利益前年比 | 184.4% | 70.8% |
| EPS（希薄化後） | $0.12 | $3.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $814.9M | ||
| Q3 25 | $956.0M | $733.8M | ||
| Q2 25 | $654.8M | $759.2M | ||
| Q1 25 | $620.4M | $664.2M | ||
| Q4 24 | $665.2M | $599.9M | ||
| Q3 24 | $478.7M | $550.3M | ||
| Q2 24 | $486.3M | $507.5M | ||
| Q1 24 | $404.4M | $493.0M |
| Q4 25 | $6.6M | $233.6M | ||
| Q3 25 | $373.0K | $207.9M | ||
| Q2 25 | $9.4M | $266.7M | ||
| Q1 25 | $6.7M | $180.4M | ||
| Q4 24 | $-7.8M | $136.8M | ||
| Q3 24 | $16.1M | $128.0M | ||
| Q2 24 | $19.2M | $103.8M | ||
| Q1 24 | $14.8M | $76.3M |
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 46.0% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 44.5% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | 42.1% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 35.3% |
| Q4 25 | 1.9% | 35.9% | ||
| Q3 25 | 2.0% | 35.7% | ||
| Q2 25 | 3.1% | 34.4% | ||
| Q1 25 | 3.3% | 34.2% | ||
| Q4 24 | 0.1% | 29.8% | ||
| Q3 24 | 5.9% | 30.7% | ||
| Q2 24 | 6.2% | 27.3% | ||
| Q1 24 | 7.5% | 22.6% |
| Q4 25 | 0.7% | 28.7% | ||
| Q3 25 | 0.0% | 28.3% | ||
| Q2 25 | 1.4% | 35.1% | ||
| Q1 25 | 1.1% | 27.2% | ||
| Q4 24 | -1.2% | 22.8% | ||
| Q3 24 | 3.4% | 23.3% | ||
| Q2 24 | 3.9% | 20.5% | ||
| Q1 24 | 3.7% | 15.5% |
| Q4 25 | $0.12 | $3.86 | ||
| Q3 25 | $0.01 | $3.43 | ||
| Q2 25 | $0.19 | $4.40 | ||
| Q1 25 | $0.14 | $2.98 | ||
| Q4 24 | $-0.14 | $2.26 | ||
| Q3 24 | $0.33 | $2.12 | ||
| Q2 24 | $0.40 | $1.72 | ||
| Q1 24 | $0.31 | $1.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $302.8M |
| 総負債低いほど良い | — | $47.5M |
| 株主資本純資産 | $779.3M | $1.0B |
| 総資産 | $2.2B | $1.6B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.05× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $302.8M | ||
| Q3 25 | $463.4M | $177.2M | ||
| Q2 25 | $342.1M | $149.7M | ||
| Q1 25 | $260.9M | $151.0M | ||
| Q4 24 | $290.8M | $133.1M | ||
| Q3 24 | $350.3M | $165.2M | ||
| Q2 24 | $327.7M | $126.3M | ||
| Q1 24 | $337.3M | $102.5M |
| Q4 25 | — | $47.5M | ||
| Q3 25 | — | $133.8M | ||
| Q2 25 | — | $250.0M | ||
| Q1 25 | — | $340.0M | ||
| Q4 24 | — | $406.3M | ||
| Q3 24 | — | $552.5M | ||
| Q2 24 | — | $708.1M | ||
| Q1 24 | — | $877.5M |
| Q4 25 | $779.3M | $1.0B | ||
| Q3 25 | $775.5M | $828.4M | ||
| Q2 25 | $765.5M | $668.3M | ||
| Q1 25 | $745.4M | $436.1M | ||
| Q4 24 | $712.7M | $290.4M | ||
| Q3 24 | $704.6M | $188.1M | ||
| Q2 24 | $678.9M | $95.1M | ||
| Q1 24 | $653.5M | $25.9M |
| Q4 25 | $2.2B | $1.6B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.2B | $1.2B |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.37× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 2.94× | ||
| Q2 24 | — | 7.45× | ||
| Q1 24 | — | 33.92× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $263.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $260.3M |
| FCFマージンFCF / 売上 | -0.6% | 31.9% |
| 設備投資強度設備投資 / 売上 | 0.3% | 0.4% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 1.13× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $699.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $263.9M | ||
| Q3 25 | $10.0M | $198.5M | ||
| Q2 25 | $90.9M | $130.4M | ||
| Q1 25 | $16.6M | $123.6M | ||
| Q4 24 | $-10.9M | $152.4M | ||
| Q3 24 | $34.0M | $233.7M | ||
| Q2 24 | $23.2M | $231.4M | ||
| Q1 24 | $6.0M | $163.9M |
| Q4 25 | $-6.0M | $260.3M | ||
| Q3 25 | $7.4M | $193.3M | ||
| Q2 25 | $89.5M | $125.2M | ||
| Q1 25 | $13.6M | $120.7M | ||
| Q4 24 | $-13.5M | $150.4M | ||
| Q3 24 | $31.7M | $231.1M | ||
| Q2 24 | $20.4M | $229.5M | ||
| Q1 24 | $5.6M | $160.6M |
| Q4 25 | -0.6% | 31.9% | ||
| Q3 25 | 0.8% | 26.3% | ||
| Q2 25 | 13.7% | 16.5% | ||
| Q1 25 | 2.2% | 18.2% | ||
| Q4 24 | -2.0% | 25.1% | ||
| Q3 24 | 6.6% | 42.0% | ||
| Q2 24 | 4.2% | 45.2% | ||
| Q1 24 | 1.4% | 32.6% |
| Q4 25 | 0.3% | 0.4% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 0.3% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 0.6% | 0.4% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | -0.44× | 1.13× | ||
| Q3 25 | 26.69× | 0.95× | ||
| Q2 25 | 9.65× | 0.49× | ||
| Q1 25 | 2.48× | 0.68× | ||
| Q4 24 | — | 1.11× | ||
| Q3 24 | 2.11× | 1.83× | ||
| Q2 24 | 1.21× | 2.23× | ||
| Q1 24 | 0.40× | 2.15× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
